Patents by Inventor Alice Luong

Alice Luong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11903954
    Abstract: The present disclosure provides phospholipid-containing compounds, pharmaceutical compositions and microspheres that exhibit high affinity for mineralized metals. The present disclosure also provides strategies for using said compounds, compositions and microspheres in the treatment of nephrolithiasis or kidney stone disease, and methods of manufacturing and preparing said compounds and compositions.
    Type: Grant
    Filed: August 2, 2022
    Date of Patent: February 20, 2024
    Assignee: APPLAUD MEDICAL, INC.
    Inventors: Daniel J. Laser, Alice Luong, Robert G. Miotke
  • Patent number: 11844807
    Abstract: The present disclosure provides phospholipid-containing compounds, pharmaceutical compositions and microspheres that exhibit high affinity for mineralized metals. The present disclosure also provides strategies for using said compounds, compositions and microspheres in the treatment of nephrolithiasis or kidney stone disease, and methods of manufacturing and preparing said compounds and compositions.
    Type: Grant
    Filed: August 2, 2022
    Date of Patent: December 19, 2023
    Assignee: Applaud Medical, Inc.
    Inventors: Daniel J. Laser, Alice Luong, Robert G. Miotke
  • Publication number: 20220395517
    Abstract: The present disclosure provides phospholipid-containing compounds, pharmaceutical compositions and microspheres that exhibit high affinity for mineralized metals. The present disclosure also provides strategies for using said compounds, compositions and microspheres in the treatment of nephrolithiasis or kidney stone disease, and methods of manufacturing and preparing said compounds and compositions.
    Type: Application
    Filed: August 2, 2022
    Publication date: December 15, 2022
    Inventors: Daniel J. Laser, Alice Luong, Robert G. Miotke
  • Publication number: 20220387458
    Abstract: The present disclosure provides phospholipid-containing compounds, pharmaceutical compositions and microspheres that exhibit high affinity for mineralized metals. The present disclosure also provides strategies for using said compounds, compositions and microspheres in the treatment of nephrolithiasis or kidney stone disease, and methods of manufacturing and preparing said compounds and compositions.
    Type: Application
    Filed: August 2, 2022
    Publication date: December 8, 2022
    Inventors: Daniel J. Laser, Alice Luong, Robert G. Miotke
  • Patent number: 11464792
    Abstract: The present disclosure provides phospholipid-containing compounds, pharmaceutical compositions and microspheres that exhibit high affinity for mineralized metals. The present disclosure also provides strategies for using said compounds, compositions and microspheres in the treatment of nephrolithiasis or kidney stone disease, and methods of manufacturing and preparing said compounds and compositions.
    Type: Grant
    Filed: January 22, 2021
    Date of Patent: October 11, 2022
    Assignee: Applaud Medical, Inc.
    Inventors: Daniel J. Laser, Alice Luong, Robert G. Miotke
  • Publication number: 20210236524
    Abstract: The present disclosure provides phospholipid-containing compounds, pharmaceutical compositions and microspheres that exhibit high affinity for mineralized metals. The present disclosure also provides strategies for using said compounds, compositions and microspheres in the treatment of nephrolithiasis or kidney stone disease, and methods of manufacturing and preparing said compounds and compositions.
    Type: Application
    Filed: January 22, 2021
    Publication date: August 5, 2021
    Inventors: Daniel J. Laser, Alice Luong, Robert G. Miotke
  • Patent number: 10953023
    Abstract: The present disclosure provides phospholipid-containing compounds, pharmaceutical compositions and microspheres that exhibit high affinity for mineralized metals. The present disclosure also provides strategies for using said compounds, compositions and microspheres in the treatment of nephrolithiasis or kidney stone disease, and methods of manufacturing and preparing said compounds and compositions.
    Type: Grant
    Filed: January 28, 2020
    Date of Patent: March 23, 2021
    Assignee: Applaud Medical, Inc.
    Inventors: Daniel J. Laser, Alice Luong, Robert G. Miotke
  • Publication number: 20200000944
    Abstract: Compositions and methods for molecular imaging of selectins are disclosed. Specifically, compositions comprising medical imaging contrast-producing agents associated with the extracellular domain of TIM-1 as a targeting ligand for use in molecular imaging of selectins are disclosed. Also, methods of using the extracellular domain of TIM-1 as a ligand for achieving specific targeting to selectins as therapeutic drug delivery vehicles is also disclosed.
    Type: Application
    Filed: March 4, 2019
    Publication date: January 2, 2020
    Applicant: Trust-Biosonics, Inc.
    Inventors: Joshua L. Rychak, Alice Luong
  • Patent number: 10265424
    Abstract: Compositions and methods for molecular imaging of selectins are disclosed. Specifically, compositions comprising medical imaging contrast-producing agents associated with the extracellular domain of TIM-1 as a targeting ligand for use in molecular imaging of selectins are disclosed. Also, methods of using the extracellular domain of TIM-1 as a ligand for achieving specific targeting to selectins as therapeutic drug delivery vehicles is also disclosed.
    Type: Grant
    Filed: March 4, 2015
    Date of Patent: April 23, 2019
    Assignee: Trust-Biosonics, Inc.
    Inventors: Joshua L. Rychak, Alice Luong
  • Publication number: 20150250903
    Abstract: Compositions and methods for molecular imaging of selectins are disclosed. Specifically, compositions comprising medical imaging contrast-producing agents associated with the extracellular domain of TIM-1 as a targeting ligand for use in molecular imaging of selectins are disclosed. Also, methods of using the extracellular domain of TIM-1 as a ligand for achieving specific targeting to selectins as therapeutic drug delivery vehicles is also disclosed.
    Type: Application
    Filed: March 4, 2015
    Publication date: September 10, 2015
    Applicant: Targeson, Inc.
    Inventors: Joshua L. Rychak, Alice Luong
  • Publication number: 20150219636
    Abstract: Methods, compositions and a two-chamber apparatus are provided for use in the separation of a biological substances type from a complex liquid mixture utilizing buoyant microbubble compositions.
    Type: Application
    Filed: January 28, 2015
    Publication date: August 6, 2015
    Applicant: Targeson, Inc.
    Inventors: Joshua L. Rychak, Dan J. Smith, Alice Luong, B. Jack DeFranco
  • Patent number: 8575359
    Abstract: The invention is in general directed to acid-sensitive linkers, and methods of use thereof, such as, for example, in drug delivery methods.
    Type: Grant
    Filed: April 4, 2007
    Date of Patent: November 5, 2013
    Assignee: The Regents of the University of California
    Inventors: Jerry Yang, Seong Deok Kong, Alice Luong, Stephen Howell
  • Publication number: 20110053878
    Abstract: The invention is in general directed to acid-sensitive linkers, and methods of use thereof, such as, for example, in drug delivery methods.
    Type: Application
    Filed: April 4, 2007
    Publication date: March 3, 2011
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Jerry Yang, Seong Deok Kong, Alice Luong, Stephen Howell